{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:51:11Z","timestamp":1789696271535,"version":"4.0.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","nanomedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.nano.2017.06.021","type":"journal-article","created":{"date-parts":[[2017,7,13]],"date-time":"2017-07-13T04:41:30Z","timestamp":1499920890000},"page":"2303-2312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Amphotericin B releasing topical nanoemulsion for the treatment of candidiasis and aspergillosis"],"prefix":"10.1016","volume":"13","author":[{"given":"Lilian","family":"Sosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Clares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen L.","family":"Alvarado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Bozal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Domenech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C.","family":"Calpena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2017.06.021_bb0005","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1073\/pnas.1117280109","article-title":"Amphotericin primarily kills yeast by simply binding ergosterol","volume":"109","author":"Gray","year":"2012","journal-title":"Proc Natl Acad Sci U SA"},{"issue":"1\u20132","key":"10.1016\/j.nano.2017.06.021_bb0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijpharm.2014.07.004","article-title":"New amphotericin B-gamma cyclodextrin formulation for topical use with synergistic activity against diverse fungal species and Leishmania spp","volume":"473","author":"Ruiz","year":"2014","journal-title":"Int J Pharm"},{"issue":"Suppl. 1","key":"10.1016\/j.nano.2017.06.021_bb0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijantimicag.2006.03.013","article-title":"What is the current and future status of conventionalAmphotericin B?","volume":"27","author":"Kleinberg","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.nano.2017.06.021_bb0020","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.colsurfb.2013.02.001","article-title":"Lipid-based microtubes for topical delivery of amphotericin B","volume":"107","author":"Salerno","year":"2013","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.nano.2017.06.021_bb0025","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1002\/jps.21330","article-title":"Structure-permeability relationship analysis of the permeation barrier properties of the stratum corneum and viable epidermis\/dermis of rat skin","volume":"97","author":"Yamaguchi","year":"2008","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.nano.2017.06.021_bb0030","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.carbpol.2014.09.032","article-title":"Development of alginate microspheres as nystatin carriers for oral mucosa drug delivery","volume":"117","author":"Mart\u00edn","year":"2015","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.nano.2017.06.021_bb0035","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.colsurfb.2015.12.003","article-title":"Topical amphotericin B in ultradeformable liposomes: formulation, skin penetration study, antifungal and antileishmanial activity in vitro","volume":"139","author":"Perez","year":"2016","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"1","key":"10.1016\/j.nano.2017.06.021_bb0040","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.nano.2013.06.002","article-title":"Amphotericin B releasing nanoparticle topical treatment of Candida spp. in the setting of a burn wound","volume":"10","author":"Sanchez","year":"2014","journal-title":"Nanomedicine"},{"issue":"4","key":"10.1016\/j.nano.2017.06.021_bb0045","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3109\/08982104.2014.995670","article-title":"Nanoethosomal formulation for skin targeting of amphotericin B: an in vitro and in vivo assessment","volume":"25","author":"Kaur","year":"2015","journal-title":"J Liposome Res"},{"key":"10.1016\/j.nano.2017.06.021_bb0050","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ijpharm.2007.04.028","article-title":"Liposomal amphotericin B eye drops to treat fungal keratitis: physico-chemical and formulation stability","volume":"344","author":"Morand","year":"2007","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.nano.2017.06.021_bb0055","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1439-0507.2012.02202.x","article-title":"Evaluation of novel nystatin nanoemulsion for skin candidosis infections","volume":"56","author":"Fern\u00e1ndez-Campos","year":"2013","journal-title":"Mycoses"},{"key":"10.1016\/j.nano.2017.06.021_bb0060","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1166\/jbn.2012.1385","article-title":"Amphotericin B-loaded nanocarriers for topical treatment of cutaneous leishmaniasis: development, characterization, and in vitro skin permeation studies","volume":"8","author":"Santos","year":"2012","journal-title":"J Biomed Nanotechnol"},{"issue":"5","key":"10.1016\/j.nano.2017.06.021_bb0065","doi-asserted-by":"crossref","first-page":"780","DOI":"10.3109\/03639045.2014.902957","article-title":"Enhanced stability and permeation potential of nanoemulsion containing sefsol-218 oil for topical delivery of amphotericin B","volume":"41","author":"Hussain","year":"2015","journal-title":"Drug Dev Ind Pharm"},{"issue":"3","key":"10.1016\/j.nano.2017.06.021_bb0070","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.nano.2016.12.002","article-title":"New perspectives in the topical delivery of optimized amphotericin B loaded nanoemulsions using excipients with innate anti-fungal activities: a mechanistic and histopathological investigation","volume":"13","author":"Hussain","year":"2017","journal-title":"Nanomedicine"},{"issue":"8","key":"10.1016\/j.nano.2017.06.021_bb0075","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.3109\/10717544.2016.1153747","article-title":"Formulation and optimization of nanoemulsion using antifungal lipid and surfactant for accentuated topical delivery of amphotericin B","volume":"23","author":"Hussain","year":"2016","journal-title":"Drug Deliv"},{"key":"10.1016\/j.nano.2017.06.021_bb0080","series-title":"Stability Testing of new Drug Substances and Products, Q1A (R2)","article-title":"International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human use","year":"2003"},{"key":"10.1016\/j.nano.2017.06.021_bb0085","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1002\/jps.23711","article-title":"Formulation design and optimization for the improvement of nystatin\u2013loaded lipid intravenous emulsion","volume":"102","author":"Mar\u00edn-Quintero","year":"2013","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.nano.2017.06.021_bb0090","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1469-0691.2007.01935.x","volume":"14","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.nano.2017.06.021_bb0095","series-title":"Reference method for broth dilution antifungal susceptibility testing of filamentous Fungi: Approved Standard\u2013Second Edition. CLSI Document M38 A2","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2008"},{"key":"10.1016\/j.nano.2017.06.021_bb0100","first-page":"438","volume":"L142","year":"2008","journal-title":"J Eur Union"},{"key":"10.1016\/j.nano.2017.06.021_bb0105","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.colsurfb.2013.12.009","article-title":"Development and characterization of two nano-structured systems for topical application of flavanones isolated from Eysenhardtia Platycarpa","volume":"116","author":"Dom\u00ednguez-Villegas","year":"2014","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"20","key":"10.1016\/j.nano.2017.06.021_bb0110","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World medical association declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.nano.2017.06.021_bb0115","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/srt.12037","article-title":"International guidelines for the in vivo assessment of skin properties in non-clinical settings: part 2. Transepidermal water loss and skin hydration","volume":"19","author":"du Plessis","year":"2013","journal-title":"Skin Res Technol"},{"issue":"3","key":"10.1016\/j.nano.2017.06.021_bb0120","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.bbamem.2013.11.015","article-title":"Effect of lactose permease presence on the structure and nanomechanics of two-component supported lipid bilayers","volume":"1838","author":"Su\u00e1rez-Germ\u00e0","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nano.2017.06.021_bb0125","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-3659(00)00325-4","article-title":"NMR characterisation and transdermal drug delivery potential of microemulsion systems","volume":"69","author":"Kreilgaard","year":"2000","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2017.06.021_bb0130","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.colsurfb.2015.03.062","article-title":"Nanoemulsions for dermal controlled release of oleanolic and ursolic acids: in vitro, ex vivo and in vivo characterization","volume":"130","author":"Alvarado","year":"2015","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.nano.2017.06.021_bb0135","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1002\/jps.23249","article-title":"Development and characterization of a novel nystatin-loaded nanoemulsion for the buccal treatment of candidosis: ultra-structural effects and release studies","volume":"101","author":"Fernandez Campos","year":"2012","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.nano.2017.06.021_bb0140","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijpharm.2003.10.037","article-title":"Characterization of caprylocaproyl macrogolglycerides based microemulsion drug delivery vehicles for an amphiphilic drug","volume":"27","author":"Djordjevic","year":"2004","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.nano.2017.06.021_bb0145","first-page":"114","article-title":"Influence of transcutol CG on the skin accumulation and trasdermal permeation og ultraviolet absorbers","volume":"23","author":"Godwin","year":"2002","journal-title":"Eur J Pharm Biopharm"},{"issue":"9","key":"10.1016\/j.nano.2017.06.021_bb0150","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.2042-7158.1991.tb03548.x","article-title":"Development and evaluation of an intracutaneous depot formulation of corticosteroids using Transcutol as a cosolvent: in-vitro, ex-vivo and in-vivo rat studies","volume":"43","author":"Panchagnula","year":"1991","journal-title":"J Pharm Pharmacol"},{"issue":"2","key":"10.1016\/j.nano.2017.06.021_bb0155","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2217\/nnm.14.102","article-title":"Developing cutaneous applications of paromomycin entrapped in stimuli-sensitive block copolymer nanogel dispersions","volume":"10","author":"Brugu\u00e9s","year":"2015","journal-title":"Nanomedicine (Lond)"},{"issue":"3","key":"10.1016\/j.nano.2017.06.021_bb0160","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jdermsci.2012.10.013","article-title":"In vivo and in vitro evaluation of the use of a newly developed melatonin loaded emulsion combined with UV filters as a protective agent against skin irradiation","volume":"69","author":"Sierra","year":"2013","journal-title":"J Dermatol Sci"},{"issue":"8","key":"10.1016\/j.nano.2017.06.021_bb0165","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00403-014-1484-4","article-title":"Semisolid formulations containing cetirizine: human skin permeation and topical antihistaminic evaluation in a rabbit model","volume":"306","author":"Ciurlizza","year":"2014","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"10.1016\/j.nano.2017.06.021_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.carbpol.2013.01.005","article-title":"Novel microparticulate systems for the vaginal delivery of nystatin: development and characterization","volume":"94","author":"Mart\u00edn-Villena","year":"2013","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.nano.2017.06.021_bb0175","series-title":"Drug Product Design and Performance, Controlled Drug Bioavailability","first-page":"203","article-title":"Mathematical Modeling of Diffusion Processes in Drug Delivery Polymeric Systems","volume":"volume 1","author":"Peppas","year":"1984"},{"key":"10.1016\/j.nano.2017.06.021_bb0180","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijpharm.2010.12.020","article-title":"Modeling of drug release from bulk-degrading polymers","volume":"418","author":"Lao","year":"2011","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2017.06.021_bb0185","first-page":"298","article-title":"Susceptibility to fluconazole and amphotericin B in clinical Candida isolates","volume":"15","author":"Mart\u00ednez","year":"1998","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.nano.2017.06.021_bb0190","series-title":"Antifungal Agents, Breakpoint Tables for Interpretation of MICs, Version 8.0","first-page":"1","author":"European Committee on antimicrobial susceptibility testing (EUCAST)","year":"2015"},{"key":"10.1016\/j.nano.2017.06.021_bb0195","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1128\/AAC.45.5.1456-1462.2001","article-title":"Susceptibility testing of aspergillus flavus: inoculum dependence with itraconazole and lack of correlation between susceptibility to amphotericin B in vitro and outcome in vivo","volume":"45","author":"Mosquera","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.nano.2017.06.021_bb0200","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/jac\/dki455","article-title":"Water-soluble amphotericin B-polyvinylpyrrolidone complexes with maintained antifungal activity against Candida spp. and aspergillus spp. and reduced haemolytic and cytotoxic effects","volume":"57","author":"Charvalos","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.nano.2017.06.021_bb0205","first-page":"456","article-title":"Skin density in the hairless rat. Evidence of regional differences","volume":"3","author":"Rins","year":"1991","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.nano.2017.06.021_bb0210","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejps.2013.09.009","article-title":"Influence of skin penetration enhancers on skin barrier function and skin protease activity","volume":"51","author":"Mohammed","year":"2014","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.nano.2017.06.021_bb0215","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2174\/1567201053586056","article-title":"Development of novel lyophilized mixed micelle amphotericin B formulation for treatment of systemic fungal infection","volume":"2","author":"Naik","year":"2005","journal-title":"Curr Drug Deliv"},{"key":"10.1016\/j.nano.2017.06.021_bb0220","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.actatropica.2016.02.026","article-title":"Hemoglobin guided nanocarrier for specific delivery of amphotericin B to Leishmania infected macrophage","volume":"158","author":"Bose","year":"2016","journal-title":"Acta Trop"},{"issue":"3","key":"10.1016\/j.nano.2017.06.021_bb0225","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10286-002-0043-9","article-title":"How is the circadian rhythm of core body temperature regulated?","volume":"12","author":"Kruchi","year":"2002","journal-title":"Clin Auton Res"},{"issue":"1\u20132","key":"10.1016\/j.nano.2017.06.021_bb0230","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ijpharm.2014.10.012","article-title":"Influence of lidocaine hydrochloride and penetration enhancers on the barrier function of human skin","volume":"477","author":"Hirata","year":"2014","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2017.06.021_bb0235","series-title":"Atomic Force Microscopy: Biomedical Methods and Applications","first-page":"179","article-title":"Imaging Bacterial Shape, Surface, and Appendages before and after Treatment with Antibiotics","author":"Braga","year":"2004"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963417301314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963417301314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T03:27:07Z","timestamp":1535599627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963417301314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S1549963417301314"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2017.06.021","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amphotericin B releasing topical nanoemulsion for the treatment of candidiasis and aspergillosis","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2017.06.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}